Eirion Overview

  • Founded
  • 2016

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $43M

  • Investors
  • 6

Eirion General Information

Description

Developer of prescription products intended for aesthetic dermatology. The company's products focus on the treatment of wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying, thereby enabling patients to get rid of problems like lateral canthal lines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 25-K Olympia Avenue
  • Suite 200
  • Woburn, MA 01801-6399
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eirion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 09-Mar-2021 $43M 0000 Completed Clinical Trials - Phase 2
1. Spin-Off 01-Jan-2016 Completed Startup
To view Eirion’s complete valuation and funding history, request access »

Eirion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of prescription products intended for aesthetic dermatology. The company's products focus on the treatment of
Drug Discovery
Woburn, MA
0000
00000000000 0000

000 00

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
000000000000000
Charleston, SC
000 As of 0000
00.000
00.00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eirion Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000 000000 Corporate Backed or Acquired Charleston, SC 000 00.000 000000&0
You’re viewing 1 of 1 competitors. Get the full list »

Eirion Patents

Eirion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020274082-A1 Delaying peak effect and/or extending duration of response Pending 14-May-2019 0000000000
CA-3139983-A1 Delaying peak effect and/or extending duration of response Pending 14-May-2019 0000000000
EP-3969038-A1 Delaying peak effect and/or extending duration of response Pending 14-May-2019 0000000000
US-20220296503-A1 Delaying peak effect and/or extending duration of response Pending 14-May-2019 00000000000
AU-2019391791-A1 Improved delivery of large agents Pending 03-Dec-2018 A61K8/66
To view Eirion’s complete patent history, request access »

Eirion Executive Team (3)

Name Title Board Seat Contact Info
Jon Edelson MD Founder, Chief Executive Officer, Chairman & President
Ron Goldstein Chief Financial Officer
Klaus Theobald Ph.D Chief Research & Development Officer
To view Eirion’s complete executive team members history, request access »

Eirion Board Members (5)

Name Representing Role Since
Albert Hummel Self Board Member 000 0000
Barry Kurokawa Self Board Member 000 0000
Carter Meyer JD Self Board Member 000 0000
Jon Edelson MD Eirion Founder, Chief Executive Officer, Chairman & President 000 0000
Kevin Finney Self Vice Chairman 000 0000
To view Eirion’s complete board members history, request access »

Eirion Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gore Range Capital Venture Capital Minority 000 0000 000000 0
Shanghai Hao Hai Healthcare Corporation Minority 000 0000 000000 0
Praesideo Management Hedge Fund Minority 000 0000 000000 0
Scientific Health Development Venture Capital Minority 000 0000 000000 0
The Spring Bay Companies Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »